| Document |
Document Title |
|
WO/2011/035790A1 |
The illness hair loss - week hair - inabilities lengthen hair - easy break up hair-scalp baldness. All are phenomena on the human being scalp hair; our invention contains a chosen mix of Natural - Pure - Genuine - Plant oils. Each oil co...
|
|
WO/2010/016683A9 |
The present invention relates to a composition for preventing and treating alopecia or for hair growth, containing a phytosphingosine-1-phosphate derivative or a pharmaceutically acceptable salt thereof. Further, the present invention pr...
|
|
WO/2011/023287A1 |
The invention relates to flavone acetic acid, its derivatives and its use in compositions, especially topical, cosmetic and/or personal care compositions, and compositions containing flavone acetic acid and/or its derivatives.
|
|
WO/2010/091199A9 |
|
|
WO/2011/007337A2 |
The present invention is directed to the use, in particular cosmetic use, of an effective amount of at least one lacritin-type polypeptide, of an analogue thereof or of a fragment thereof, of at least one nucleic acid sequence encoding t...
|
|
WO/2011/000903A2 |
The present invention relates to the cosmetic use of jasmonic acid derivatives of formula (I), in which: R1 represents a radical COOR3, R3 denoting a hydrogen atom or a C1-C4 alkyl radical, optionally substituted with one or more hydroxy...
|
|
WO/2010/146622A1 |
Provided are drugs, external preparations and cosmetics having an effect of inhibiting NFAT signal, an effect of inhibiting calcineurin and an effect of promoting hair growth. An NFAT signal inhibitor which comprises as the active ingred...
|
|
WO/2010/139660A2 |
Disclosed is a composition containing ginger and camomile or ginger with camphor and various plant extracts and/or essential oils. Uses of said composition are also disclosed.
|
|
WO/2010/138422A1 |
The present invention provides a method for the treatment of alopecia and/or enhancing hair growth in a patient, wherein said method comprises administering, preferably topically, to the skin, e.g. the scalp or the eyelid, a therapeutica...
|
|
WO/2010/123184A1 |
The present invention relates to a pharmaceutical composition, a cosmetic composition and health foods for preventing and treating alopecia disorder containing norgalanthamine compounds as an active ingredient. The norgalanthamine compou...
|
|
WO/2010/121922A1 |
Hair treatment composition comprising an azole fungicide and zinc gluconate and wherein the composition does not comprise Trichogen®.
|
|
WO/2010/121919A1 |
A hair treatment composition comprising a trichogenic material and from 0.0002 to 0.0049% wt. of an additional anti-dandruff agent.
|
|
WO/2007/099503A9 |
A method of reducing hair growth includes topical application of a TRPM8 and/or a TRPAl agonist, alone or in conjunction with heat.
|
|
WO/2010/110863A2 |
The present invention relates to compositions and methods for promoting hair growth, particularly to compositions and methods for promoting growth of eyelash and/or scalp hair. The compositions and methods are capable of making hair much...
|
|
WO/2010/106904A1 |
Disclosed is a hair growing and nourishing agent which contains, as an active ingredient, at least one compound selected from a group of compounds represented by general formula (1) or a queen's delight extract that contains at least one...
|
|
WO/2010/107287A2 |
The present invention relates to a medium for fetal mesenchymal stem cells from amniotic fluid. More specifically, the present invention relates to a composition for trichogenousness or preventing depilation, which comprises the medium f...
|
|
WO/2010/093768A2 |
Various embodiments of the present invention are directed to hair-loss, and include treatments and preparations. Embodiments of the present invention include bactericides, combinations of bactericides and fungicides, combination of bacte...
|
|
WO/2010/091894A2 |
Disclosed herein are methods for treating hair related disorders, including compounds that may be specific or modulate PPAR receptors.
|
|
WO/2010/091529A1 |
A pharmaceutical composition comprising effective amount of silver nanoparticles and extracts of Polygonum Multiforum Thunb, a method for increasing hair growth by administering the said pharmaceutical composition locally to a host, and ...
|
|
WO/2010/090590A1 |
An apparatus for treatment of skin or hair thinning/balding ailments on the scalp of a human, wherein the apparatus comprises treatment carriers (3), a guide means (1) having a curved configuration, and holding means (2) connected to the...
|
|
WO/2010/082024A2 |
A topical composition comprising at least one active agent selected from a depilatory agent (s), an agent (s) for preventing or reducing the growth or re-growth of hair and an agent (s) for preventing or reducing in-growing hair, and a g...
|
|
WO/2010/082001A2 |
The invention relates to a product for preventing or treating hair greying, including an extract of the Radix Polygoni Multiflori root and an active ingredient enhancing or maintaining hair growth packaged together in a single compositio...
|
|
WO/2010/072959A2 |
The present invention relates to a depilatory composition including: hydrogenated or unhydrogenated rosin, and/or rosin derivatives selected from glycerol-, triethylene glycol- pentaerythritol- or trimethylolpropane-esterified rosin; and...
|
|
WO/2010/067212A2 |
The present invention refers to a complex of vegetal source active stem cells, including stem cells of Malus Domestica, stem cells of Buddleja Davidii amd preferably Teprenone, and to a cosmetic composition for topical use, which contain...
|
|
WO/2010/064203A1 |
The invention relates to the cosmetic use, by the oral and/or topical route, of combinations of reduced glutathione or one of its antioxidant analogues or precursors and two or more amino acids chosen from glutamic acid, threonine, gluta...
|
|
WO/2010/063673A2 |
The invention relates to cosmetic compositions to be applied topically to inhibit hair growth, which compositions contain at least one compound of the group of the advanced glycation end products (AGEs) and/or the precursors thereof, pre...
|
|
WO/2010/063678A2 |
The invention relates to cosmetic and dermatological deodorant or antiperspirant compositions which contain at least one deodorant or antiperspirant active substance and at least one compound of the group of advanced glycation end produc...
|
|
WO/2010/058517A1 |
Disclosed are a pharmaceutical or food composition for improving a memory/learning ability by a convenient and safe means and a method for improving a memory/learning ability. Specifically disclosed is a nerve cell stimulator comprising...
|
|
WO/2010/056759A1 |
The present invention provides methods for treating hair loss, treating, inhibiting, or suppressing a degenerative skin disorder, treating androgenetic alopecia (AGA), generating new hair follicles (HF), and increasing the size of existi...
|
|
WO/2010/055833A1 |
Provided is a composition for inhibiting FGF-5 having excellent inhibiting activity against FGF-5. This composition comprises at least one selected from rice bran/soy bean fermentation product; extract of flower petals of the genus Rosa...
|
|
WO/2010/047103A1 |
Disclosed are an NFAT signal inhibitor and others. Specifically disclosed are: an NFAT signal inhibitor comprising, as an active ingredient, at least one compound selected from the group consisting of a coumarin derivative represented by...
|
|
WO/2010/027040A1 |
Provided is novel medicinal use of a 15,15-difluoroprostaglandin F2α derivative. As a result of intensive studies in order to discover novel medicinal use of a 15,15-difluoroprostaglandin F2α derivative, it was found that, in Phase II...
|
|
WO/2010/021034A1 |
A skin preparation for external use, e.g., a skin-lightening agent or hair growth accelerator, which contains a highly-water-soluble compound having a specific structure capable of releasing 2,3-dimethoxy-5-methyl-1,4-dihydroxybenzene (r...
|
|
WO/2010/016606A2 |
A hair growth regulating agent containing, as an active ingredient, a compound represented by the following formula (I): [wherein R1 represents a substituted or unsubstituted, linear or branched C2 to C25 alkyl group; a group represented...
|
|
WO/2010/013191A2 |
A cosmetic composition activatable by the application of a low frequency alternating electromagnetic field (ELF), and relative cosmetic process for the rapid eu-physiological functional recovery of hair follicles. The cosmetic process en...
|
|
WO/2009/150421A2 |
A synergistic composition, or the use of that composition in the manufacture of a medicament, or a method of treatment including the use of that composition, for the treatment of hair loss and baldness, for combined, sequential or simult...
|
|
WO/2009/151212A2 |
The present invention relates to uses of ginseng flower extract and ginseng seed extract. The ginseng seed extract comprises ginseng seed oil or ginseng seed skin extract. The uses include skin protection, antiaging, antiwrinkle, improve...
|
|
WO/2009/151828A1 |
This invention relates to compositions and processes for stimulating the growth of mammalian hair comprising the topical application of compositions comprising a hair growth stimulating and/or hair loss prevention agent, and a hair and/o...
|
|
WO/2009/144929A1 |
Although zinc pyrithione is known as a good anti-dandruff ingredient, the blending amount needs to be decreased without lowering the effects in consideration of environmental pollution. For zinc pyrithione used as an antifouling coating...
|
|
WO/2009/142200A1 |
A method for growing or nourishing head hair characterized by repeating washing of head hair using a wash solution containing a micro-bubble-washing composition containing a proteolytic enzyme and a fat-splitting enzyme, and micro-bubble...
|
|
WO/2009/116098A9 |
The inventions relates to a composition for the treatment of eyelashes, eyebrows or of hair comprising a compound having the formula (I): wherein R is hydrogen or C1-C4 alkyl.
|
|
WO/2009/113435A1 |
A sugar derivative preparation which contains an Aphanothece sacrum-derived specific sugar derivative G1 or G2 as an active ingredient and is used for various functional purposes such as water absorption, antimicrobial use, anticancer us...
|
|
WO/2009/109426A1 |
The invention relates to an extract from the goji berry (Lycium Barbarum) that is especially suitable for use in the treatment of keratin fibres, in particular human hair, for improving moisture retention in the fibres, for repairing and...
|
|
WO/2009/109402A2 |
The invention describes a combination of at least one aromatase inhibitor selected from the group of chemical-synthetic aromatase inhibitors and extracts of soya beans and rapeseed having aromatase inhibition function, and at least one p...
|
|
WO/2009/109425A1 |
The invention relates to a fruit extract from acai (Euterpe oleracea) that is especially suitable for use in the treatment of keratin fibres, in particular human hair, for improving moisture retention in the fibre, for repairing and reco...
|
|
WO/2009/107074A1 |
Disclosed in a hair care composition comprising: a hair care composition comprises: A) a hair diameter increasing agent comprising: a xanthine compound; a vitamine B3 compound; and a panthenol compound; B) an additional benefit agent, su...
|
|
WO/2009/107073A1 |
Disclosed is a method for increasing hair diameter, comprising the steps of: topically applying a first composition comprising to a region where hair diameter increase is desired; and topically applying a second composition to a region w...
|
|
WO/2009/107072A1 |
Disclosed in a hair care composition comprising: (i) a hair diameter increasing agent comprising a xanthine compound, a vitamin B3 compound, and a panthenol compound; and (ii) an carrier comprising water and monohydric alcohols having 1 ...
|
|
WO/2009/107075A1 |
Disclosed in a hair care composition comprising: (i) a deposition agent which is in a solid particulate form on the hair; (ii) an adhesive agent which adhere the deposition agent to the hair; and (iii) an carrier; wherein either or both ...
|
|
WO/2009/101497A2 |
The present invention relates to a fixed dose topical pharmaceutical formulation comprising minoxidil and aminexil, processes for preparing such formulation and their method of use for the treatment of alopecia in human.
|
